Cart
sales@molnova.com
HEC72702
CAS No. 1793063-59-8
HEC72702 ( HEC-72702;HEC 72702 )
Catalog No. M12703 CAS No. 1793063-59-8
HEC72702 is a novel potent, orally active inhibitor of HBV capsid assembly, inhibits HBV-DNA levels in HepG.2.2.15 cells with IC50 of 39 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1143 | Get Quote |
|
| 50MG | 2322 | Get Quote |
|
| 100MG | 3060 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHEC72702
-
NoteResearch use only, not for human use.
-
Brief DescriptionHEC72702 is a novel potent, orally active inhibitor of HBV capsid assembly, inhibits HBV-DNA levels in HepG.2.2.15 cells with IC50 of 39 nM.
-
DescriptionHEC72702 is a novel potent, orally active inhibitor of HBV capsid assembly, inhibits HBV-DNA levels in HepG.2.2.15 cells with IC50 of 39 nM; displays no induction of the CYP1A2, CYP3A4, or CYP2B6 enzyme at 10 uM, demonstrates a good systemic exposure and high oral bioavailability and achieves a viral-load reduction greater than 2 log in a hydrodynamic-injected (HDI) HBV mouse model.
-
SynonymsHEC-72702;HEC 72702
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1793063-59-8
-
Formula Weight581.46
-
Molecular FormulaC24H26BrFN4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCC)C1=C(NC(C2=NC=CS2)=N[C@H]1C3=C(Br)C=C(F)C=C3)CN4CCO[C@H](CCC(O)=O)C4
-
Chemical Name3-((R)-4-(((R)-6-(2-Bromo-4- fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)- 3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ren Q, et al. J Med Chem. 2018 Feb 8;61(3):1355-1374.
molnova catalog
related products
-
IR415
IR415 is a novel small molecule inhibitor of HBV virus replication that blocks hepatitis B virus X protein (HBx, Kd=2 nM) mediated RNAi suppression.
-
RO6889678
RO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.
-
Besifovir(b)
Besifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
